According to Latest Study, the global market for Bacteriophage should grow from US$ 37 million in 2022 to US$ 121.4 million by 2029, with a CAGR of 18.8% for the period of 2023-2029.
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report studies and analyses global Bacteriophage status and future trends, to help determine the Bacteriophage market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Bacteriophage, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Bacteriophage market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Bacteriophage by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Bacteriophage by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Bacteriophage key consuming regions, consumption value and demand structure
(5) Bacteriophage industry chains, upstream, midstream and downstream
Market segment by players, this report covers
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Market segment by Type, covers
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Market segment by Application, can be divided into
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Bacteriophage product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Bacteriophage market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Bacteriophage market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Bacteriophage industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Bacteriophage Definition
1.2 Global Bacteriophage Market Size and Forecast
1.3 China Bacteriophage Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Bacteriophage Market Size: China VS Global Growth Rate, 2018-2029
1.6 Bacteriophage Market Dynamics
1.6.1 Bacteriophage Market Drivers
1.6.2 Bacteriophage Market Restraints
1.6.3 Bacteriophage Industry Trends
1.6.4 Bacteriophage Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Bacteriophage, Global Market Share by Company, 2018-2023
2.2 Global Bacteriophage Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Bacteriophage Concentration Ratio
2.4 Global Bacteriophage Mergers & Acquisitions, Expansion Plans
2.5 Global Bacteriophage Major Companies Product Type
2.6 Head Office and Bacteriophage Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Bacteriophage, China Market Share by Company, 2018-2023
3.2 China Bacteriophage Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Bacteriophage Industry Chain
4.2 Bacteriophage Upstream Analysis
4.2.1 Bacteriophage Core Raw Materials
4.2.2 Main Manufacturers of Bacteriophage Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Bacteriophage Production Mode
4.6 Bacteriophage Procurement Model
4.7 Bacteriophage Industry Sales Model and Sales Channels
4.7.1 Bacteriophage Sales Model
4.7.2 Bacteriophage Typical Distributors
5 Sights by Type
5.1 Bacteriophage Classification
5.1.1 DsDNA Bacteriophage
5.1.2 SsDNA Bacteriophage
5.1.3 SsRNA Bacteriophage
5.1.4 Others
5.2 By Type, Global Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Bacteriophage Consumption Value, 2018-2029
6 Sights by Application
6.1 Bacteriophage Segment by Application
6.1.1 Animal Health
6.1.2 Aquaculture
6.1.3 Agriculture
6.1.4 Food Industry
6.1.5 Human Health
6.1.6 Others
6.2 By Application, Global Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Bacteriophage Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Bacteriophage Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Bacteriophage Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Bacteriophage & Forecasts, 2018-2029
7.3.2 By Country, North America Bacteriophage Market Size Market Share
7.4 Europe
7.4.1 Europe Bacteriophage Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Bacteriophage Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Bacteriophage Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Bacteriophage Market Size Market Share
7.6 South America
7.6.1 South America Bacteriophage Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Bacteriophage Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Bacteriophage Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Bacteriophage Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Bacteriophage Market Size, 2018-2029
8.3.2 By Type, U.S. Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Bacteriophage Market Size, 2018-2029
8.4.2 By Type, Europe Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Bacteriophage Market Size, 2018-2029
8.5.2 By Type, China Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Bacteriophage Market Size, 2018-2029
8.6.2 By Type, Japan Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Bacteriophage Market Size, 2018-2029
8.7.2 By Type, South Korea Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Bacteriophage Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Bacteriophage Market Size, 2018-2029
8.9.2 By Type, India Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Bacteriophage Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Bacteriophage Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Bacteriophage Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 NPO Microgen
9.1.1 NPO Microgen Company Information, Head Office, Market Area and Industry Position
9.1.2 NPO Microgen Company Profile and Main Business
9.1.3 NPO Microgen Bacteriophage Models, Specifications and Application
9.1.4 NPO Microgen Bacteriophage Revenue and Gross Margin, 2018-2023
9.1.5 NPO Microgen Recent Developments
9.2 Proteon Pharmaceuticals
9.2.1 Proteon Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.2.2 Proteon Pharmaceuticals Company Profile and Main Business
9.2.3 Proteon Pharmaceuticals Bacteriophage Models, Specifications and Application
9.2.4 Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin, 2018-2023
9.2.5 Proteon Pharmaceuticals Recent Developments
9.3 Phagelux
9.3.1 Phagelux Company Information, Head Office, Market Area and Industry Position
9.3.2 Phagelux Company Profile and Main Business
9.3.3 Phagelux Bacteriophage Models, Specifications and Application
9.3.4 Phagelux Bacteriophage Revenue and Gross Margin, 2018-2023
9.3.5 Phagelux Recent Developments
9.4 Intralytix
9.4.1 Intralytix Company Information, Head Office, Market Area and Industry Position
9.4.2 Intralytix Company Profile and Main Business
9.4.3 Intralytix Bacteriophage Models, Specifications and Application
9.4.4 Intralytix Bacteriophage Revenue and Gross Margin, 2018-2023
9.4.5 Intralytix Recent Developments
9.5 Micreos
9.5.1 Micreos Company Information, Head Office, Market Area and Industry Position
9.5.2 Micreos Company Profile and Main Business
9.5.3 Micreos Bacteriophage Models, Specifications and Application
9.5.4 Micreos Bacteriophage Revenue and Gross Margin, 2018-2023
9.5.5 Micreos Recent Developments
9.6 Eliava BioPreparations
9.6.1 Eliava BioPreparations Company Information, Head Office, Market Area and Industry Position
9.6.2 Eliava BioPreparations Company Profile and Main Business
9.6.3 Eliava BioPreparations Bacteriophage Models, Specifications and Application
9.6.4 Eliava BioPreparations Bacteriophage Revenue and Gross Margin, 2018-2023
9.6.5 Eliava BioPreparations Recent Developments
9.7 Locus Biosciences, Inc
9.7.1 Locus Biosciences, Inc Company Information, Head Office, Market Area and Industry Position
9.7.2 Locus Biosciences, Inc Company Profile and Main Business
9.7.3 Locus Biosciences, Inc Bacteriophage Models, Specifications and Application
9.7.4 Locus Biosciences, Inc Bacteriophage Revenue and Gross Margin, 2018-2023
9.7.5 Locus Biosciences, Inc Recent Developments
9.8 Pharmex Group, LLC
9.8.1 Pharmex Group, LLC Company Information, Head Office, Market Area and Industry Position
9.8.2 Pharmex Group, LLC Company Profile and Main Business
9.8.3 Pharmex Group, LLC Bacteriophage Models, Specifications and Application
9.8.4 Pharmex Group, LLC Bacteriophage Revenue and Gross Margin, 2018-2023
9.8.5 Pharmex Group, LLC Recent Developments
9.9 Pherecydes Pharma
9.9.1 Pherecydes Pharma Company Information, Head Office, Market Area and Industry Position
9.9.2 Pherecydes Pharma Company Profile and Main Business
9.9.3 Pherecydes Pharma Bacteriophage Models, Specifications and Application
9.9.4 Pherecydes Pharma Bacteriophage Revenue and Gross Margin, 2018-2023
9.9.5 Pherecydes Pharma Recent Developments
9.10 APS Biocontrol Ltd. (APS)
9.10.1 APS Biocontrol Ltd. (APS) Company Information, Head Office, Market Area and Industry Position
9.10.2 APS Biocontrol Ltd. (APS) Company Profile and Main Business
9.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Models, Specifications and Application
9.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin, 2018-2023
9.10.5 APS Biocontrol Ltd. (APS) Recent Developments
9.11 Qingdao Phagepharm Bio-tech
9.11.1 Qingdao Phagepharm Bio-tech Company Information, Head Office, Market Area and Industry Position
9.11.2 Qingdao Phagepharm Bio-tech Company Profile and Main Business
9.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Models, Specifications and Application
9.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin, 2018-2023
9.11.5 Qingdao Phagepharm Bio-tech Recent Developments
9.12 Fixed-Phage Limited
9.12.1 Fixed-Phage Limited Company Information, Head Office, Market Area and Industry Position
9.12.2 Fixed-Phage Limited Company Profile and Main Business
9.12.3 Fixed-Phage Limited Bacteriophage Models, Specifications and Application
9.12.4 Fixed-Phage Limited Bacteriophage Revenue and Gross Margin, 2018-2023
9.12.5 Fixed-Phage Limited Recent Developments
9.13 Zeptometrix
9.13.1 Zeptometrix Company Information, Head Office, Market Area and Industry Position
9.13.2 Zeptometrix Company Profile and Main Business
9.13.3 Zeptometrix Bacteriophage Models, Specifications and Application
9.13.4 Zeptometrix Bacteriophage Revenue and Gross Margin, 2018-2023
9.13.5 Zeptometrix Recent Developments
9.14 Phage International, Inc.
9.14.1 Phage International, Inc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Phage International, Inc. Company Profile and Main Business
9.14.3 Phage International, Inc. Bacteriophage Models, Specifications and Application
9.14.4 Phage International, Inc. Bacteriophage Revenue and Gross Margin, 2018-2023
9.14.5 Phage International, Inc. Recent Developments
9.15 MicroMir
9.15.1 MicroMir Company Information, Head Office, Market Area and Industry Position
9.15.2 MicroMir Company Profile and Main Business
9.15.3 MicroMir Bacteriophage Models, Specifications and Application
9.15.4 MicroMir Bacteriophage Revenue and Gross Margin, 2018-2023
9.15.5 MicroMir Recent Developments
9.16 iNtODEWORLD, Inc.
9.16.1 iNtODEWORLD, Inc. Company Information, Head Office, Market Area and Industry Position
9.16.2 iNtODEWORLD, Inc. Company Profile and Main Business
9.16.3 iNtODEWORLD, Inc. Bacteriophage Models, Specifications and Application
9.16.4 iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin, 2018-2023
9.16.5 iNtODEWORLD, Inc. Recent Developments
9.17 NEXTBIOTICS
9.17.1 NEXTBIOTICS Company Information, Head Office, Market Area and Industry Position
9.17.2 NEXTBIOTICS Company Profile and Main Business
9.17.3 NEXTBIOTICS Bacteriophage Models, Specifications and Application
9.17.4 NEXTBIOTICS Bacteriophage Revenue and Gross Margin, 2018-2023
9.17.5 NEXTBIOTICS Recent Developments
9.18 Armata Pharmaceuticals, Inc.
9.18.1 Armata Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
9.18.2 Armata Pharmaceuticals, Inc. Company Profile and Main Business
9.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Models, Specifications and Application
9.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin, 2018-2023
9.18.5 Armata Pharmaceuticals, Inc. Recent Developments
9.19 Innophage
9.19.1 Innophage Company Information, Head Office, Market Area and Industry Position
9.19.2 Innophage Company Profile and Main Business
9.19.3 Innophage Bacteriophage Models, Specifications and Application
9.19.4 Innophage Bacteriophage Revenue and Gross Margin, 2018-2023
9.19.5 Innophage Recent Developments
9.20 Adaptive Phage Therapeutics
9.20.1 Adaptive Phage Therapeutics Company Information, Head Office, Market Area and Industry Position
9.20.2 Adaptive Phage Therapeutics Company Profile and Main Business
9.20.3 Adaptive Phage Therapeutics Bacteriophage Models, Specifications and Application
9.20.4 Adaptive Phage Therapeutics Bacteriophage Revenue and Gross Margin, 2018-2023
9.20.5 Adaptive Phage Therapeutics Recent Developments
9.21 TechnoPhage
9.21.1 TechnoPhage Company Information, Head Office, Market Area and Industry Position
9.21.2 TechnoPhage Company Profile and Main Business
9.21.3 TechnoPhage Bacteriophage Models, Specifications and Application
9.21.4 TechnoPhage Bacteriophage Revenue and Gross Margin, 2018-2023
9.21.5 TechnoPhage Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Bacteriophage Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Bacteriophage Market Restraints
Table 3. Bacteriophage Market Trends
Table 4. Bacteriophage Industry Policy
Table 5. Global Bacteriophage Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Bacteriophage Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Bacteriophage Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Bacteriophage Mergers & Acquisitions, Expansion Plans
Table 9. Global Bacteriophage Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Bacteriophage Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Bacteriophage Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Bacteriophage Upstream (Raw Materials)
Table 14. Global Bacteriophage Typical Customers
Table 15. Bacteriophage Typical Distributors
Table 16. By Type, Global Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Bacteriophage Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Bacteriophage Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Bacteriophage Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Bacteriophage Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Bacteriophage Consumption Value Market Share, 2018-2029
Table 23. NPO Microgen Company Information, Head Office, Market Area and Industry Position
Table 24. NPO Microgen Company Profile and Main Business
Table 25. NPO Microgen Bacteriophage Models, Specifications, and Application
Table 26. NPO Microgen Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. NPO Microgen Recent Developments
Table 28. Proteon Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 29. Proteon Pharmaceuticals Company Profile and Main Business
Table 30. Proteon Pharmaceuticals Bacteriophage Models, Specifications, and Application
Table 31. Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Proteon Pharmaceuticals Recent Developments
Table 33. Phagelux Company Information, Head Office, Market Area and Industry Position
Table 34. Phagelux Company Profile and Main Business
Table 35. Phagelux Bacteriophage Models, Specifications, and Application
Table 36. Phagelux Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Phagelux Recent Developments
Table 38. Intralytix Company Information, Head Office, Market Area and Industry Position
Table 39. Intralytix Company Profile and Main Business
Table 40. Intralytix Bacteriophage Models, Specifications, and Application
Table 41. Intralytix Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Intralytix Recent Developments
Table 43. Micreos Company Information, Head Office, Market Area and Industry Position
Table 44. Micreos Company Profile and Main Business
Table 45. Micreos Bacteriophage Models, Specifications, and Application
Table 46. Micreos Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Micreos Recent Developments
Table 48. Eliava BioPreparations Company Information, Head Office, Market Area and Industry Position
Table 49. Eliava BioPreparations Company Profile and Main Business
Table 50. Eliava BioPreparations Bacteriophage Models, Specifications, and Application
Table 51. Eliava BioPreparations Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Eliava BioPreparations Recent Developments
Table 53. Locus Biosciences, Inc Company Information, Head Office, Market Area and Industry Position
Table 54. Locus Biosciences, Inc Company Profile and Main Business
Table 55. Locus Biosciences, Inc Bacteriophage Models, Specifications, and Application
Table 56. Locus Biosciences, Inc Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Locus Biosciences, Inc Recent Developments
Table 58. Pharmex Group, LLC Company Information, Head Office, Market Area and Industry Position
Table 59. Pharmex Group, LLC Company Profile and Main Business
Table 60. Pharmex Group, LLC Bacteriophage Models, Specifications, and Application
Table 61. Pharmex Group, LLC Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Pharmex Group, LLC Recent Developments
Table 63. Pherecydes Pharma Company Information, Head Office, Market Area and Industry Position
Table 64. Pherecydes Pharma Company Profile and Main Business
Table 65. Pherecydes Pharma Bacteriophage Models, Specifications, and Application
Table 66. Pherecydes Pharma Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Pherecydes Pharma Recent Developments
Table 68. APS Biocontrol Ltd. (APS) Company Information, Head Office, Market Area and Industry Position
Table 69. APS Biocontrol Ltd. (APS) Company Profile and Main Business
Table 70. APS Biocontrol Ltd. (APS) Bacteriophage Models, Specifications, and Application
Table 71. APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. APS Biocontrol Ltd. (APS) Recent Developments
Table 73. Qingdao Phagepharm Bio-tech Company Information, Head Office, Market Area and Industry Position
Table 74. Qingdao Phagepharm Bio-tech Company Profile and Main Business
Table 75. Qingdao Phagepharm Bio-tech Bacteriophage Models, Specifications, and Application
Table 76. Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Qingdao Phagepharm Bio-tech Recent Developments
Table 78. Fixed-Phage Limited Company Information, Head Office, Market Area and Industry Position
Table 79. Fixed-Phage Limited Company Profile and Main Business
Table 80. Fixed-Phage Limited Bacteriophage Models, Specifications, and Application
Table 81. Fixed-Phage Limited Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Fixed-Phage Limited Recent Developments
Table 83. Zeptometrix Company Information, Head Office, Market Area and Industry Position
Table 84. Zeptometrix Company Profile and Main Business
Table 85. Zeptometrix Bacteriophage Models, Specifications, and Application
Table 86. Zeptometrix Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Zeptometrix Recent Developments
Table 88. Phage International, Inc. Company Information, Head Office, Market Area and Industry Position
Table 89. Phage International, Inc. Company Profile and Main Business
Table 90. Phage International, Inc. Bacteriophage Models, Specifications, and Application
Table 91. Phage International, Inc. Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Phage International, Inc. Recent Developments
Table 93. MicroMir Company Information, Head Office, Market Area and Industry Position
Table 94. MicroMir Company Profile and Main Business
Table 95. MicroMir Bacteriophage Models, Specifications, and Application
Table 96. MicroMir Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. MicroMir Recent Developments
Table 98. iNtODEWORLD, Inc. Company Information, Head Office, Market Area and Industry Position
Table 99. iNtODEWORLD, Inc. Company Profile and Main Business
Table 100. iNtODEWORLD, Inc. Bacteriophage Models, Specifications, and Application
Table 101. iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. iNtODEWORLD, Inc. Recent Developments
Table 103. NEXTBIOTICS Company Information, Head Office, Market Area and Industry Position
Table 104. NEXTBIOTICS Company Profile and Main Business
Table 105. NEXTBIOTICS Bacteriophage Models, Specifications, and Application
Table 106. NEXTBIOTICS Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. NEXTBIOTICS Recent Developments
Table 108. Armata Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
Table 109. Armata Pharmaceuticals, Inc. Company Profile and Main Business
Table 110. Armata Pharmaceuticals, Inc. Bacteriophage Models, Specifications, and Application
Table 111. Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. Armata Pharmaceuticals, Inc. Recent Developments
Table 113. Innophage Company Information, Head Office, Market Area and Industry Position
Table 114. Innophage Company Profile and Main Business
Table 115. Innophage Bacteriophage Models, Specifications, and Application
Table 116. Innophage Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 117. Innophage Recent Developments
Table 118. Adaptive Phage Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 119. Adaptive Phage Therapeutics Company Profile and Main Business
Table 120. Adaptive Phage Therapeutics Bacteriophage Models, Specifications, and Application
Table 121. Adaptive Phage Therapeutics Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 122. Adaptive Phage Therapeutics Recent Developments
Table 123. TechnoPhage Bacteriophage Company Information, Head Office, Market Area and Industry Position
Table 124. TechnoPhage Company Profile and Main Business
Table 125. TechnoPhage Bacteriophage Models, Specifications, and Application
Table 126. TechnoPhage Bacteriophage Revenue and Gross Margin, US$ Million, 2018-2023
Table 127. TechnoPhage Recent Developments
List of Figures
Figure 1. Bacteriophage Picture
Figure 2. Global Bacteriophage Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Bacteriophage Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Bacteriophage Market Share of Global, 2018-2029
Figure 5. Global Bacteriophage Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Bacteriophage Key Participants, Market Share, 2022
Figure 7. Bacteriophage Industry Chain
Figure 8. Bacteriophage Procurement Model
Figure 9. Bacteriophage Sales Model
Figure 10. Bacteriophage Sales Channels, Direct Sales, and Distribution
Figure 11. DsDNA Bacteriophage
Figure 12. SsDNA Bacteriophage
Figure 13. SsRNA Bacteriophage
Figure 14. Others
Figure 15. By Type, Global Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 16. By Type, Global Bacteriophage Consumption Value Market Share, 2018-2029
Figure 17. Animal Health
Figure 18. Aquaculture
Figure 19. Agriculture
Figure 20. Food Industry
Figure 21. Human Health
Figure 22. Others
Figure 23. By Application, Global Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 24. By Application, Global Bacteriophage Consumption Value Market Share, 2018-2029
Figure 25. By Region, Global Bacteriophage Consumption Value Market Share, 2018-2029
Figure 26. North America Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, North America Bacteriophage Consumption Value Market Share, 2022
Figure 28. Europe Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, Europe Bacteriophage Consumption Value Market Share, 2022
Figure 30. Asia Pacific Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country/Region, Asia Pacific Bacteriophage Consumption Value Market Share, 2022
Figure 32. South America Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. By Country, South America Bacteriophage Consumption Value Market Share, 2022
Figure 34. Middle East & Africa Bacteriophage Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 35. U.S. Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 36. By Type, U.S. Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 37. By Application, U.S. Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 38. Europe Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 39. By Type, Europe Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 40. By Application, Europe Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 41. China Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 42. By Type, China Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 43. By Application, China Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 44. Japan Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 45. By Type, Japan Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 46. By Application, Japan Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 47. South Korea Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 48. By Type, South Korea Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 50. Southeast Asia Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 51. By Type, Southeast Asia Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 53. India Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 54. By Type, India Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 55. By Application, India Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 56. Middle East & Africa Bacteriophage Consumption Value, 2018-2029, US$ Million
Figure 57. By Type, Middle East & Africa Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 58. By Application, Middle East & Africa Bacteriophage Consumption Value Market Share, 2022 VS 2029
Figure 59. Research Methodology
Figure 60. Breakdown of Primary Interviews
Figure 61. Bottom-up and Top-down Approaches
Figure 62. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|